15 Frequently Asked Questions : Leukemia, Lymphoma and Blood Cancer Treatments in India for Bangladeshi Patients

Q1 · What are leukemia, lymphoma and other blood cancers?

Blood cancers are a group of cancers affecting the blood-forming tissues, bone marrow, lymphatic system or immune cells.

The major categories include

• Leukemia — cancer involving blood-forming tissues and abnormal blood cells, commonly originating in the bone marrow.
• Lymphoma — cancer affecting lymphocytes, a type of white blood cell, and commonly involving lymph nodes or other lymphatic tissues.
• Multiple myeloma — a cancer of plasma cells, which are immune cells responsible for producing antibodies.
• Myelodysplastic syndromes and related blood disorders — conditions affecting normal blood-cell production and, in some cases, potentially progressing to acute leukemia.
• Other hematological malignancies — less common cancers involving blood, bone marrow or immune-system cells.

Leukemia may be broadly classified into acute or chronic forms, while lymphoma is commonly divided into Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment is highly diagnosis-specific. Two patients with apparently similar symptoms may require very different treatment approaches. For this reason, accurate pathology, immunophenotyping, molecular testing and disease classification are important before starting major treatment.

Q2 · How much does leukemia, lymphoma and blood cancer treatment cost in Bangladesh compared with India?

The cost of blood-cancer treatment varies substantially depending on the exact diagnosis, disease stage, treatment protocol, medicines required, number of chemotherapy cycles, need for targeted or immunotherapy, hospitalization, complications and whether stem cell transplantation is required.

For planning purposes, this guide uses

• US$1 ≈ BDT 122
• US$1 ≈ INR 96

Indicative Cost Comparison

These figures are indicative planning ranges only. Actual costs can vary significantly depending on the cancer type, treatment protocol, medicines, complications, hospital category, length of admission and need for transplantation or intensive supportive care.

Patients should ask whether the quotation includes

• Doctor consultation charges
• Diagnostic investigations
• Bone-marrow testing
• Pathology and molecular testing
• Chemotherapy medicines
• Targeted or immunotherapy medicines
• Hospital admission
• Doctor and nursing charges
• Blood and platelet transfusions
• Infection management
• ICU care, if required
• Central-line or catheter-related procedures
• Stem cell collection, where applicable
• Transplant-related medicines
• Follow-up consultations
• Additional procedures and investigations

Patients should obtain a detailed written quotation based on their individual diagnosis and treatment plan before travelling to India. A lower initial estimate may not represent the final treatment cost if additional medicines, investigations, hospitalization or complications occur.

Q3 · Which Indian cities can Bangladeshi patients consider for leukemia, lymphoma and blood cancer treatment?

Bangladeshi patients can consider major Indian medical centres in several cities, depending on the required hematology, oncology, transplant and supportive-care services.

The appropriate city should be selected according to the patient's diagnosis, treatment requirements, specialist availability, transplant needs and expected duration of treatment.

Q4 · Which hospitals in India can Bangladeshi patients consider for leukemia, lymphoma and blood cancer treatment?

Hospital selection should be based on the patient's specific blood-cancer diagnosis and the services required rather than hospital name alone.

Q5 · What types of leukemia, lymphoma and blood cancer treatments are available in India?

Depending on the diagnosis, Indian cancer centres may provide several treatment approaches.

1. Chemotherapy

Chemotherapy uses anti-cancer medicines to destroy or control abnormal cancer cells. Protocols vary considerably according to the specific leukemia or lymphoma.

2. Targeted Therapy

Targeted medicines act on particular molecular or cellular characteristics of cancer cells. Their use depends on the patient's pathology and molecular findings.

3. Immunotherapy

Some blood cancers can be treated with medicines that help the immune system recognize and attack abnormal cells.

4. Radiotherapy

Radiotherapy may be used for selected lymphoma cases or particular disease-related problems.

5. Stem Cell Transplantation

Stem cell transplantation may be considered for selected patients with leukemia, lymphoma, multiple myeloma and other hematological malignancies.

It may involve

• Autologous transplantation
• Allogeneic transplantation
• Donor stem cells
• Conditioning treatment
• Stem-cell collection and infusion

6. CAR-T Cell Therapy

For selected blood cancers, cellular therapies such as CAR-T may be considered depending on disease type, treatment history, eligibility and availability.

7. Supportive Treatment

Supportive care may include

• Blood transfusions
• Platelet transfusions
• Infection treatment
• Antibiotics and antifungal medicines
• Nutritional support
• Pain management
• Management of treatment-related complications

The appropriate combination is determined by the treating hemato-oncology team.

Q6 · Who may be suitable for leukemia, lymphoma or blood cancer treatment in India?

Bangladeshi patients may seek evaluation in India when they require

• Confirmation of a blood-cancer diagnosis
• A second medical opinion
• Advanced pathology or molecular testing
• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiotherapy
• Stem cell transplantation
• Management of relapsed or refractory disease
• Treatment planning after previous therapy
• Assessment for clinical or cellular-therapy options, where applicable

Patients who have already received treatment in Bangladesh can also send their previous reports for preliminary medical review. Suitability for a particular treatment cannot be determined from symptoms alone. The treating specialist generally needs the complete diagnosis, pathology, blood results, imaging and previous-treatment history.

Q7 · What tests are required before leukemia, lymphoma or blood cancer treatment?

The exact investigations depend on the suspected or confirmed disease.

Common investigations may include

• Complete blood count
• Peripheral blood smear
• Bone marrow aspiration
• Bone marrow biopsy
• Flow cytometry
• Immunophenotyping
• Cytogenetic testing
• Molecular or genetic testing
• Biopsy of an affected lymph node, where required
• Histopathology
• Immunohistochemistry
• PET-CT or CT scan for selected lymphoma cases
• MRI or other imaging when clinically indicated
• Liver-function tests
• Kidney-function tests
• Electrolyte testing
• Infection screening
• Blood-group testing
• Cardiac assessment before selected therapies
• Pulmonary assessment when clinically indicated

For some leukemias, molecular and cytogenetic findings can significantly influence treatment selection. Patients should not assume that every test is required for every type of blood cancer.

Q8 · What medical records should Bangladeshi patients send before travelling to India?

Patients should ideally send a complete and organized medical record before travelling.

Important documents may include

• Current diagnosis
• Previous pathology reports
• Bone-marrow reports
• Flow-cytometry reports
• Immunohistochemistry reports
• Molecular and genetic test results
• Complete blood-count reports
• Previous imaging reports
• PET-CT or CT reports, where applicable
• Previous chemotherapy protocols
• Previous radiotherapy details
• Stem-cell transplant records, if applicable
• Current medication list
• Blood-transfusion history
• Details of previous treatment response
• Reports describing relapse or disease progression
• Previous hospital discharge summaries
• Current symptoms
• Recent blood-test results
• Identification and passport information for international-patient coordination

Patients should send the most recent reports wherever possible. If reports are available in Bengali, patients may be asked to provide an English translation or summary for easier review.

Q9 · How does leukemia, lymphoma and blood cancer treatment work?

Treatment depends primarily on the exact disease classification.

Leukemia

Treatment may involve combinations of chemotherapy, targeted therapy, immunotherapy and, for selected patients, stem cell transplantation.

Acute leukemia may require intensive treatment and close monitoring because abnormal cells can multiply rapidly.

Lymphoma

Lymphoma treatment depends on the type and stage. Treatment may include chemotherapy, immunotherapy, targeted medicines, radiotherapy or combinations of these approaches.

Multiple Myeloma

Treatment may involve combinations of anti-myeloma medicines, targeted agents, immunomodulatory medicines, steroids and, for selected patients, autologous stem cell transplantation.

Stem Cell Transplantation

When transplantation is appropriate, the general process may involve

• Detailed eligibility assessment
• Disease-control treatment
• Donor evaluation where required
• Stem-cell collection
• Conditioning therapy
• Stem-cell infusion
• Close monitoring
• Infection prevention
• Management of complications
• Long-term follow-up

The patient's response to treatment is monitored through blood tests, imaging, bone-marrow evaluation and other disease-specific investigations.

Q10 · What are the alternatives to leukemia, lymphoma and blood cancer treatment?

There is no single alternative treatment applicable to all blood cancers.

Depending on the diagnosis and disease status, options may include

• Active surveillance for selected slow-growing diseases
• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiotherapy
• Stem cell transplantation
• Cellular therapies for selected patients
• Combination treatment
• Supportive or palliative treatment when disease-directed treatment is not appropriate

For some patients, treatment may be sequential rather than a single procedure. A second opinion may be useful when the diagnosis is complex, when treatment options are uncertain, when disease has returned or when transplantation is being considered.

Q11 · What should Bangladeshi patients ask before accepting a blood-cancer treatment quotation?

Patients should ask the treating team clear questions before committing to treatment.

About Diagnosis

• What exact type of blood cancer does the patient have?
• What is the disease stage or risk category?
• Has the diagnosis been confirmed by pathology?
• Are additional molecular or genetic tests required?
• Is another pathology review recommended?

About Treatment

• What treatment protocol is being proposed?
• Why has this treatment been recommended?
• How many treatment cycles may be required?
• Will chemotherapy be inpatient or outpatient?
• Are targeted medicines required?
• Is immunotherapy required?
• Is radiotherapy required?
• Is stem cell transplantation being considered?
• Is donor testing necessary?
• Are cellular therapies relevant to the patient's case?

About Cost

• What is included in the treatment quotation?
• Are medicines included?
• Are diagnostic tests included?
• Are blood and platelet transfusions included?
• What happens if the patient develops complications?
• Are ICU charges included if required?
• Is the estimate per cycle or for the complete treatment plan?
• What additional expenses should the family budget for?

About Travel and Follow-up

• How long should the patient remain in India?
• Can follow-up consultations be conducted remotely after returning to Bangladesh?

Patients should request a written treatment plan and quotation whenever possible.

Q12 · How long should Bangladeshi patients stay in India?

The required stay depends heavily on the treatment. A short consultation and diagnostic evaluation may require only several days. Chemotherapy may require repeated visits or a longer stay depending on whether treatment is provided as an outpatient or inpatient. Patients undergoing intensive treatment may need to remain in India for a substantially longer period. Stem cell transplantation generally requires a prolonged stay because the patient needs close monitoring during conditioning, transplantation and early recovery.

The treating team should provide an estimated schedule covering

• Initial consultation
• Diagnostic confirmation
• Treatment planning
• Treatment cycles
• Hospital admissions
• Follow-up
• Discharge
• Medical clearance for travel

International patients should avoid booking a fixed return date until the treating team has provided a realistic treatment and recovery timeline.

Q13 · What is recovery like after leukemia, lymphoma or blood cancer treatment?

Recovery varies according to the cancer type, treatment intensity and individual health.

Patients receiving chemotherapy may experience

• Fatigue
• Reduced appetite
• Nausea
• Temporary reduction in blood counts
• Increased infection risk
• Hair loss with some treatment regimens
• Weakness
• Mouth sores
• Changes in taste

Patients undergoing transplantation may require more prolonged monitoring and recovery.

Recovery planning may include

• Regular blood tests
• Medication management
• Infection precautions
• Nutritional support
• Adequate hydration
• Physical activity as medically advised
• Monitoring for fever or other warning signs
• Scheduled hematology follow-up

Patients should immediately contact their treating medical team if they develop concerning symptoms such as significant fever, breathing difficulty, uncontrolled bleeding or sudden deterioration.

Q14 · How can follow-up be managed after returning to Bangladesh?

Follow-up should be planned before the patient leaves India.

The Indian treating team may provide

• Discharge summary
• Final diagnosis
• Treatment protocol
• Medicines
• Follow-up schedule
• Blood-test requirements
• Imaging requirements
• Bone-marrow follow-up schedule, where applicable
• Warning signs requiring urgent medical attention
• Contact information for the treating team

The patient can continue appropriate follow-up with a hematologist or oncologist in Bangladesh while maintaining communication with the Indian treatment team when necessary.

Patients should keep digital and printed copies of

• Pathology reports
• Bone-marrow reports
• Treatment summaries
• Medication lists
• Blood-test results
• Imaging reports
• Discharge summaries

For patients undergoing prolonged treatment, coordination between the Indian and Bangladeshi medical teams can help maintain continuity of care.

Q15 · Should a Bangladeshi patient travel to India for leukemia, lymphoma or blood cancer treatment?

The decision should be based on the patient's individual medical circumstances rather than cost alone.

Before travelling, patients should consider

• Whether the diagnosis has been clearly established
• Whether the required specialist expertise is available
• Whether the necessary diagnostic tests can be completed
• Whether the proposed treatment is appropriate for the patient's disease
• Whether transplantation or specialized therapy is required
• Expected treatment duration
• Total estimated cost
• Hospitalization requirements
• Availability of medicines
• Follow-up arrangements after returning to Bangladesh
• Travel and accommodation requirements
• Emergency-care arrangements

Patients should obtain a specialist medical opinion based on their complete records before making travel arrangements.